Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy. Am J Med Genet A. 2020 07; 182(7):1576-1591.
View in:
PubMed
subject areas
Adolescent
Adult
Aneurysm
Child
Female
Genetic Association Studies
Humans
Imatinib Mesylate
Infant
Leukoencephalopathies
Male
Myofibromatosis
Pedigree
Protein Kinase Inhibitors
Receptor, Platelet-Derived Growth Factor beta
authors with profiles
William B. Dobyns